Cannabidiol in low back pain: scientific rationale for clinical trials in low back pain.

Introduction: The pooled worldwide prevalence of low-back pain-related presentations in primary care varies between 6.8% and 28.4% in the high-income countries rendering it a major healthcare/economy problem.